Touchlight will be exhibiting at ISCT Asia 2026, the International Society for Cell & Gene Therapy’s regional meeting, bringing together global and regional leaders advancing translational cell and gene therapies across Asia. Join us in Singapore to learn how cell-free DNA is supporting scalable, high‑quality DNA supply for next‑generation genetic medicines.

Visit Touchlight at Booth #4

Meet the team in the exhibition hall to discuss how our enzymatically produced cell‑free DNA enables:

• Unmatched versatility for precise gene editing
• Improved stability and safety
• Scalability for pharmaceutical applications

Touchlight Company Presentation

Join Touchlight’s company presentation as part of the ISCT Asia 2026 corporate sessions program.

Session details

• Date: Thursday, September 3, 2026
• Time: 10:30am
• Speaker: Dr. Daria Olijynk-Dallis

Schedule a meeting with the Touchlight team to discuss how we can support your DNA supply strategy.

Touchlight Attendees

Touchlight will be attending the BIO International Convention 2026, the world’s largest and most comprehensive biotechnology partnering event, bringing together more than 20,000 life sciences leaders from across the global biotech ecosystem. BIO International Convention is the premier forum for business development, scientific exchange, and strategic collaboration across biopharma, cell and gene therapy, vaccines, and emerging biotechnologies. The event features 130+ sessions across 18 focus areas, alongside extensive one‑to‑one partnering opportunities through the BIO Partnering platform.

Meet us at the UK Pavilion at Booth # 2221

At BIO 2026, the Touchlight team will be available at Booth #2221 to discuss how our cell-free DNA manufacturing technology is helping developers overcome scalability, quality, and supply challenges in advanced genetic medicines.

Schedule a meeting with the Touchlight team to discuss how we can support your DNA supply strategy.

Touchlight Attendees

Touchlight will join the global gene and cell therapy community at the ASGCT 2026 Annual Meeting, held May 11–15, 2026 at the Thomas M. Menino Convention & Exhibition Center in Boston, MA.

Visit us at booth # 1334

As a leader in cell‑free DNA manufacturing, Touchlight is shaping the next era of advanced therapy development. At ASGCT, our team will discuss how mbDNA and Custom Circles, our next‑generation, circular single‑stranded DNA formats, enable developers to move faster, overcome plasmid constraints, and streamline the path from discovery to clinic.

Throughout the meeting, our commercial and scientific experts will be onsite for discussions so if you’re attending ASGCT, we welcome you to connect with us to explore how Touchlight’s technology can accelerate your pipeline.

 

Touchlight is proud to be exhibiting at the ISCT 2026 Annual Meeting, taking place 6–9 May in Dublin. As one of the field’s leading global forums, ISCT brings together key decision‑makers and innovators shaping the future of cell and gene therapies. This year’s program showcases novel research, emerging data, and transformative ideas delivered by global key opinion leaders.

Our Presence
Touchlight will be exhibiting at Booth# 1713 and presenting our latest abstract: “Reimagining DNA payloads: Enzymatic circular DNA for the next generation of cell and gene therapies.” This work highlights our continued commitment to innovating DNA formats that unlock new therapeutic possibilities. We look forward to sharing how our enzymatically produced suite of novel circular DNA architectures supports scalable, rapid, and regulatory‑aligned CGT development.

Interested in next‑generation DNA manufacturing? Request a meeting with a Touchlight expert today.

Touchlight Attendees